Intestinal barrier in inflammatory bowel disease
- PMID: 24574793
- PMCID: PMC3921501
- DOI: 10.3748/wjg.v20.i5.1165
Intestinal barrier in inflammatory bowel disease
Abstract
A complex mucosal barrier protects as the first line of defense the surface of the healthy intestinal tract from adhesion and invasion by luminal microorganisms. In this review, we provide an overview about the major components of this protective system as for example an intact epithelium, the synthesis of various antimicrobial peptides (AMPs) and the formation of the mucus layer. We highlight the crucial importance of their correct functioning for the maintenance of a proper intestinal function and the prevention of dysbiosis and disease. Barrier disturbances including a defective production of AMPs, alterations in thickness or composition of the intestinal mucus layer, alterations of pattern-recognition receptors, defects in the process of autophagy as well as unresolved endoplasmic reticulum stress result in an inadequate host protection and are thought to play a crucial role in the pathogenesis of the inflammatory bowel diseases Crohn's disease and ulcerative colitis.
Keywords: Antimicrobial peptide; Crohn’s disease; Goblet cell; Inflammatory bowel disease; Intestinal barrier; Mucus layer; Paneth cell; Ulcerative colitis.
Figures
Similar articles
-
Microbiota and mucosal defense in IBD: an update.Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):963-976. doi: 10.1080/17474124.2019.1671822. Epub 2019 Oct 11. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31603356 Review.
-
Inflammatory bowel disease: an impaired barrier disease.Langenbecks Arch Surg. 2013 Jan;398(1):1-12. doi: 10.1007/s00423-012-1030-9. Epub 2012 Nov 18. Langenbecks Arch Surg. 2013. PMID: 23160753 Review.
-
Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.Dig Dis. 2014;32(4):475-83. doi: 10.1159/000358156. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969297 Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders.World J Gastroenterol. 2019 Jul 21;25(27):3503-3526. doi: 10.3748/wjg.v25.i27.3503. World J Gastroenterol. 2019. PMID: 31367153 Free PMC article. Review.
Cited by
-
Neutrophil-mediated type IV collagen degradation is elevated in patients with mild endoscopic ulcerative colitis reflecting early mucosal destruction.Sci Rep. 2024 Jan 18;14(1):1641. doi: 10.1038/s41598-024-52208-y. Sci Rep. 2024. PMID: 38238446 Free PMC article.
-
Enteric-Coated Cologrit Tablet Exhibit Robust Anti-Inflammatory Response in Ulcerative Colitis-like In-Vitro Models by Attuning NFκB-Centric Signaling Axis.Pharmaceuticals (Basel). 2022 Dec 31;16(1):63. doi: 10.3390/ph16010063. Pharmaceuticals (Basel). 2022. PMID: 36678560 Free PMC article.
-
Understanding disruption of the gut barrier during inflammation: Should we abandon traditional epithelial cell lines and switch to intestinal organoids?Front Immunol. 2023 Feb 16;14:1108289. doi: 10.3389/fimmu.2023.1108289. eCollection 2023. Front Immunol. 2023. PMID: 36875103 Free PMC article. Review.
-
Phillygenin Attenuated Colon Inflammation and Improved Intestinal Mucosal Barrier in DSS-induced Colitis Mice via TLR4/Src Mediated MAPK and NF-κB Signaling Pathways.Int J Mol Sci. 2023 Jan 23;24(3):2238. doi: 10.3390/ijms24032238. Int J Mol Sci. 2023. PMID: 36768559 Free PMC article.
-
Walk on the wild side: SIV infection in African non-human primate hosts-from the field to the laboratory.Front Immunol. 2023 Jan 12;13:1060985. doi: 10.3389/fimmu.2022.1060985. eCollection 2022. Front Immunol. 2023. PMID: 36713371 Free PMC article. Review.
References
-
- Wehkamp J, Stange EF. Paneth’s disease. J Crohns Colitis. 2010;4:523–531. - PubMed
-
- Goto Y, Kiyono H. Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol Rev. 2012;245:147–163. - PubMed
-
- Hindryckx P, Laukens D. Intestinal barrier dysfunction: The primary driver of IBD? Inflammatory Bowel Disease -Advances in Pathogenesis and Management, Dr. Sami Karoui (Ed.), 2012; ISBN: 978-953-307-891-5, InTech. Available from: http://www.intechopen.com/download/pdf/268396.
-
- Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical